Capital Area Research — Newport, Pennsylvania

Capital Area Research is a clinical research site located in Newport, Pennsylvania, United States 17074.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Capital Area Research has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Type 2 Diabetes Mellitus.

Sponsors: Novartis Pharmaceuticals, Janssen Research & Development, LLC, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Area Research?

Capital Area Research has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Area Research conducted?

Capital Area Research has 3 clinical trials on record, with 1 currently active. Their work covers Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Type 2 Diabetes Mellitus.

Is Capital Area Research accredited by Crixeo Health?

Capital Area Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Area Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.